FORWARD PHARMA A/S's ticker is FWP and the CUSIP is 34986J105. A total of 33 filers reported holding FORWARD PHARMA A/S in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,000 | – | 176 | +1157.1% | 0.00% | – |
| Q3 2017 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 14 | -60.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 35 | +6.1% | 0.00% | – |
| Q4 2015 | $1,000 | -85.7% | 33 | -88.9% | 0.00% | – |
| Q3 2015 | $7,000 | – | 297 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,387,853 | $28,215,000 | 4.38% |
| SENZAR ASSET MANAGEMENT, LLC | 652,500 | $13,265,000 | 3.27% |
| Baupost Group | 6,364,059 | $129,381,000 | 1.48% |
| Assured Investment Management LLC | 1,511,043 | $26,982,000 | 0.56% |
| Perceptive Advisors | 194,718 | $3,959,000 | 0.20% |
| Rhenman & Partners Asset Management AB | 36,584 | $744,000 | 0.11% |
| DRW Securities, LLC | 17,000 | $346,000 | 0.06% |
| NJ State Employees Deferred Compensation Plan | 15,000 | $305,000 | 0.06% |
| Freedom Investment Management, Inc. | 20,178 | $410,000 | 0.02% |
| Acrospire Investment Management LLC | 942 | $19,000 | 0.02% |